We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$143M
2
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$49M
3
CCVI
Churchill Capital Corp VI
CCVI
+$34.2M
4
AMD icon
Advanced Micro Devices
AMD
+$27.5M
5
CLDX icon
Celldex Therapeutics
CLDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
276
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$96K 0.01%
1,400
-38,600
-97% -$17.2M
ROSS.WS
277
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$96K 0.01%
234,197
+177,007
+310% +$94.4K
TCACW
278
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$96K 0.01%
290,226
+240,226
+480% +$96.6K
BMRN icon
279
PUT
BioMarin Pharmaceuticals
BMRN
$13.5B
$94K 0.01%
+37,500
New +$3.14M
BNIXR
280
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$92K 0.01%
459,758
-18,000
-4% -$4.12K
JUN.WS
281
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$90K 0.01%
+220,176
New +$120K
DMYS.WS
282
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$89K 0.01%
129,128
+89,128
+223% +$72.6K
DINO icon
283
HF Sinclair
DINO
$15.2B
$88K 0.01%
+2,200
New +$77.4K
LAAAW
284
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$87K 0.01%
248,131
+43,256
+21% +$17.7K
ONMDW icon
285
OneMedNet Corp Warrant
ONMDW
$1.01M
$84K 0.01%
496,431
+47,834
+11% +$12.3K
HZON.WS
286
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$83K 0.01%
126,057
+98,080
+351% +$61.8K
IGACW
287
DELISTED
IG Acquisition Corp. Warrant
IGACW
$83K 0.01%
+258,956
New +$108K
APLS
288
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$82K 0.01%
+15,100
New +$667K
TETEW
289
DELISTED
Technology & Telecommunication Acquisition Corporation Warrant
TETEW
$82K 0.01%
+494,715
New +$76.5K
TCOA.WS
290
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$82K 0.01%
+263,785
New +$100K
ZINGW
291
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$82K 0.01%
+214,627
New +$98K
ARBGW
292
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$82K 0.01%
419,595
-150,199
-26% -$58.4K
AXH.WS
293
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$82K 0.01%
+455,601
New +$103K
HYG icon
294
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$80K 0.01%
69,800
+19,800
+40% +$1.66M
PL icon
295
Planet Labs
PL
$8.45B
$80K 0.01%
15,749
– –
XBI icon
296
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$78K 0.01%
+50,000
New +$4.62M
IBM icon
297
PUT
IBM
IBM
$225B
$77K 0.01%
+15,000
New +$1.96M
DUETW
298
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$76K 0.01%
+474,900
New +$73K
SCUA.WS
299
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$75K 0.01%
+250,807
New +$101K
MX icon
300
CALL
Magnachip Semiconductor
MX
$142M
$74K 0.01%
40,300
+200
+0.5% +$3.59K
10 11
12
13 14

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.